Fair Issac Corp., Iovance Biotherapeutics, Stablecoin Development Corp., Carnival Corp. and Micron: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices ended lower on Tuesday, with the Dow Jones Industrial Average falling 0.26% to 51,349.92, the S&P 500 declining 0.17% to 7,670.84, and the Nasdaq slipping 0.09% to 26,797.54. These are the top stocks that gained the attention of retail traders and investors through the day: Fair Isaac Corporation (NYSE: FICO ) Fair Isaac Corporation's stock plummeted 26.52% to close at $617.87. It hit an intraday high of $685 and a low of $595.19, marking a new 52-week low. In after-hours trading, the stock fell 1.07% to $611.27. The stock's decline follows the announcement by FHFA Director Bill Pulte that Fannie Mae and Freddie Mac are simplifying mortgage pricing, integrating VantageScore alongside FICO Classic. This move threatens FICO's dominance in mortgage credit scoring, leading to significant investor concern. Read Also: MrBeast Returns With Another $1 Million Challenge — This Time He Wants Contestants To Eat Everything In A Grocery Store Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ) Iovance Biotherapeutics surged 31.48%, closing at $14.45, with a high of $15.30 and a low of $12.78. The stock reached a new 52-week high, driven by the company's increased revenue guidance f
S. 54. 87. 19, marking a new 52-week low.
27. The stock's decline follows the announcement by FHFA Director Bill Pulte that Fannie Mae and Freddie Mac are simplifying mortgage pricing, integrating VantageScore alongside FICO Classic. This move threatens FICO's dominance in mortgage credit scoring, leading to significant investor concern. Read Also: MrBeast Returns With Another $1 Million Challenge — This Time He Wants Contestants To Eat Everything In A Grocery Store Iovance Biotherapeutics, Inc.
78. The stock reached a new 52-week high, driven by the company's increased revenue guidance for 2026. S. demand for Amtagvi and Proleukin.
The company said increasing patient demand and manufacturing efficiencies were providing greater visibility into second-half revenue and supporting progress toward profitability. 62. 59 in extended trading. 62 million, extending a rally of more than 200% over the past month.
The company, formerly NovaBay Pharmaceuticals, had pivoted to digital-asset infrastructure in April and recently simplified its capital structure by withdrawing its Series A-F preferred stock designations while adding David Garcia Rios to its board as the Sky Frontier Foundation's nominee. 29 and a low of $24. 45. 36.
6 billion pointed to continued demand strength, with 2027 booked occupancy and pricing at record levels. Micron Technology, Inc. 08. 70.
96 and $1,255 in the past 52 weeks. 45 in EPS. JPMorgan, Bank of America and BMO pointed to sustained DRAM and HBM shortages through 2027-28, with estimates for continued mid-80% gross margins and potentially significant earnings growth as AI infrastructure demand outpaced memory supply. The report will be released on Wednesday after market closes.
Edge Stock Rankings indicate Micron stock has a Momentum score in the 99th percentile and a Value score in the 20th percentile See More: Top Momentum Stocks Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published editors. Photo: Zakharchuk / Shutterstock